X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
male (22) 22
index medicus (21) 21
middle aged (21) 21
female (19) 19
gastroenterology & hepatology (19) 19
adult (14) 14
aged (14) 14
gastroenterology and hepatology (14) 14
treatment outcome (9) 9
diagnosis (8) 8
young adult (8) 8
aged, 80 and over (7) 7
care and treatment (7) 7
internal medicine (7) 7
oncology (7) 7
adolescent (6) 6
autoimmune hepatitis (6) 6
cancer (6) 6
hepatitis (6) 6
management (6) 6
retrospective studies (6) 6
disease (5) 5
gastroenterology (5) 5
hepatitis, autoimmune - drug therapy (5) 5
hepatology (5) 5
liver diseases (5) 5
primary biliary cirrhosis (5) 5
prognosis (5) 5
therapy (5) 5
chronic active hepatitis (4) 4
digestive system diseases (4) 4
health aspects (4) 4
immunosuppressive agents - therapeutic use (4) 4
overlap syndrome (4) 4
portal hypertension (4) 4
simplified criteria (4) 4
survival (4) 4
syndrome (4) 4
ursodeoxycholic acid - therapeutic use (4) 4
abridged index medicus (3) 3
adverse effect (3) 3
chemotherapy (3) 3
cirrhosis (3) 3
clinical medicine (3) 3
combination (3) 3
drug therapy, combination (3) 3
europe (3) 3
fibrosis (3) 3
frequency (3) 3
gastroenterologi (3) 3
hepatitis, autoimmune - blood (3) 3
hepatitis, autoimmune - complications (3) 3
hepatitis, autoimmune - diagnosis (3) 3
hypertension (3) 3
klinisk medicin (3) 3
liver (3) 3
liver cirrhosis (3) 3
liver cirrhosis, biliary - complications (3) 3
liver cirrhosis, biliary - drug therapy (3) 3
liver transplantation (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
prevalence (3) 3
prospective studies (3) 3
time factors (3) 3
tumors (3) 3
adenocarcinoma - pathology (2) 2
analysis (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
ascites (2) 2
autoantibodies (2) 2
autoantibodies - blood (2) 2
autoimmune diseases - epidemiology (2) 2
autoimmune liver disease (2) 2
autoimmunity (2) 2
bacterial infections - etiology (2) 2
bezafibrate (2) 2
biliary cirrhosis (2) 2
biochemical response (2) 2
biochemistry (2) 2
biochemistry, general (2) 2
biomarkers - blood (2) 2
biopsy (2) 2
calibration (2) 2
carcinoma, hepatocellular - drug therapy (2) 2
chemical and drug induced liver injury - etiology (2) 2
child (2) 2
cholagogues and choleretics - therapeutic use (2) 2
cholangiocarcinoma (2) 2
cisplatin (2) 2
clinical trials (2) 2
comorbidity (2) 2
criteria (2) 2
delivery (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
epidemiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2017, Volume 15, Issue 12, pp. 1950 - 1956.e1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2171 - 2181
Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
Journal Article
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2016, Volume 111, Issue 10, pp. 1402 - 1409
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
AMERICAN JOURNAL OF GASTROENTEROLOGY, ISSN 0002-9270, 07/2019, Volume 114, Issue 7, pp. 1101 - 1108
INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary... 
SURVIVAL | GLOBE | PROGNOSIS | CIRRHOSIS | BIOCHEMICAL RESPONSE | HISTOLOGICAL PROGRESSION | PLACEBO-CONTROLLED TRIAL | OUTCOMES | GASTROENTEROLOGY & HEPATOLOGY | BEZAFIBRATE | PREDICTION
Journal Article